Kampo medicine (Sino-Japanese traditional herbal medicine) is widely adopted in contemporary medicine, and there are increasing evaluations of its efficacy and safety. Toki-shakuyaku-san is composed of 6 varieties of medicinal plants: toki, senkyu, shakuyaku, sojutsu, takusha, and bukuryo, and because it is efficacious due to its smooth muscle relaxation, facilitating hemopoiesis and adequate water level control in the body, etc., 1) it has long been considered effective in improving symptoms in women under a hypofunctioning condition.
rified water. A bloodletting (0.5 or 1 ml) was conducted at 10 a.m. once a week beginning on 8-week-old rats (the day the rats were started on the iron-deficient diet), and from 17-week-old rats (0.5 ml) once every 2 weeks. A hemoglobin level of 12 g/dl and a hematocrit (Ht) of 36% or less (anemia diagnostic criteria in WHO) were used as the indices for anemia in order to identify the constant anemia condition.
Group Assignment The anemic rats were divided into 4 groups according to their body weight and Hb values, an untreated group (nϭ6), a Toki-shakuyaku-san group (nϭ5), an iron-preparation group (nϭ5), and a Toki-shakuyaku-sanϩ iron-preparation group (nϭ5).
Drugs TSUMURA Toki-shakuyaku-san powder which don't contain the excipient, provided by TSUMURA & Co., were used as the Toki-shakuyaku-san. The drug contains 6 varieties of medicinal plants: toki, senkyu, shakuyaku, sojutsu, takusha, and bukuryo, and 0.8 g/kg (0.8 mg/3.33 ml/g) was set as the usual experimental dose; before administration it was dissolved as needed in purified water boiled at 100°C. Ferrous sulfate (FeSO 4 /7H 2 O, Wako Pure Chemical Industries, Ltd., special grade) was used as the iron preparation, and in order to gradually follow up the anemia-ameliorating effect, an experimental dose of 0.406 mg/kg (0.406 mg/3.33 ml/g) was administered after dissolving as needed in purified water. Once-daily oral administration of Toki-shakuyaku-san and the iron preparation at 10 a.m. was started on 11-week-old rats (after development of the anemia) and continued for 16 weeks (until rats were 27 weeks old). Purified water was administered orally to the untreated group.
Measurements of General Blood
The specimens of blood collected were used to determine the leukocyte (WBC) count, erythrocyte (RBC) count, hemoglobin (Hb), hematocrit (Ht), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), reticulocyte count, and platelet (PLT) count as general hematological parameters, and to measure serum iron (Fe), total iron-binding capacity (TIBC), and unsaturated iron-binding capacity (UIBC) as biochemical parameters. These tests were performed by SRL, Inc. and clinical laboratory test data of the healthy control rats were observed for comparison.
Measurements of Serum Transferrin and Ferritin
The blood collected from 10-week-old rats (before drug administration) and from the 27-week-old rats (following 16 weeks of drug administration) was allowed to stand at room temperature for 30 min, then centrifuged at 654ϫg for 15 min, and the transferrin and ferritin (rat transferrin and rat ferritin kits, Panapharm Laboratories Corp.) in the serum were measured by enzyme immunoassay (EIA). Serum transferrin and ferritin were measured in the same manner in healthy control rats (10 and 27-week-olds), which had not been bled nor given any drug.
Observations of External Appearance To assess the general condition of the 27-week-old drug-administered rats, the condition of their ears, eyes, mouth, tongue color, and their teeth, the color of their paws, warmth, and nails of their front and hind paws, the color of their hair, its luster, the lie of the hair, hair soiling, ease of hair loss, and the color of their tail, thickness, and pigmentation of the tail were observed and compared in each of the groups. Body temperature was determined by measuring rectal temperature at 1 p.m. The parameters observed were rated on a 5-grade scale: ϩϩϩ, ϩϩ, ϩ, Ϯ, and Ϫ.
Organ Weight and Organ Observations Body weight was measured once a week starting at the time of purchase. Necropsy was performed on the 27-week-old drug-administered rats, and the animals' organs (brain, thyroid gland, thymus gland, heart, lungs, liver, spleen, stomach, cecum, adrenals, kidneys, testes) were weighed. The stomach, small intestine (duodenum, jejunum, ileum), and large intestine (colon, rectum) were examined in detail with a stereomicroscope. The organs of healthy control rats (27-week-olds) were weighed and examined in a similar manner to obtain normal data.
Observations of Erythrocyte Morphology Heparinized blood was collected before necropsy at 27 weeks of age, a blood smear was prepared, and erythrocyte morphology was examined under a light microscope (Olympus BX50, Olympus Corporation). Erythrocytes from rats of the same age were examined to obtain normal data.
Determinations of Fecal Number, Wet Weight, and Water Content On 26-week-old rats (after 15 weeks of drug administration), the number, wet weight, and water content of feces excreted within 24 h were determined. To prevent drying, each animal's feces were placed in a covered container after each defecation, and after counting and measuring the wet weight every 8 h, to water content was determined by desiccating at 70°C for 8 h or more in a draft desiccator. The percentage of water content was calculated for each individual from the difference between the wet and dry weights. Similar measurements were made in healthy control rats of the same age.
Measurement of Fecal Iron Content
In 26-week-old rats (after 15 weeks of drug administration), iron was measured in dried feces excreted within 24 h. A 0.5 g sample of desiccated feces from each individual was placed in a test tube, 5 ml of a mixture of nitric acid and sulfuric acid (4 : 1) was added (for atomic absorption spectrometry, Kanto Kagaku) and it was allowed to stand for 2 h. The specimen was then heated at 80°C for 2 h, and after additional heating at 130°C until the sample liquid became transparent, purified water was added to a total volume of 5 ml. The measurements were made with an atomic absorption spectrometer (Polarized Zeeman Atomic Absorption Spectrophotometer Z-5000 Series, Hitachi, Ltd.).
Statistical Analysis Differences in mean values between groups were tested by multiple comparisons using the Bonferroni method. In the measurement of serum transferring and ferritin, organ weight, fecal number, wet weight and water content in feces and fecal iron content, Wilcoxon's rank-sum test was used for the statistical analysis of comparison between healthy control rats and the untreated group (anemic rats). pϽ0.05 was considered to denote statistical significance.
RESULTS

Preparation of the Anemic Rats
Eight-week-old male rats were used. One and a half milliliter of blood was collected at 2 weeks and the animals were supplied with an iron-deficient diet and purified water; 3 weeks later, at 11 weeks of age, they displayed anemia with an RBC of 616.3Ϯ10.0ϫ10 4 /ml, Hb of 11.1Ϯ0.2 g/dl, and Ht of 34.1Ϯ0.5% (Tables 1, 2) . Because of the rapid progress of the anemia, from 17 weeks onward the collected volume of blood was reduced to 0.5 ml every 2 weeks, and the anemia was mitigated thereafter (Tables 1, 2 ). An increase in MCV was observed in 19-week-old rats, but examination of erythrocyte morphology showed that the increase was attributable to some of the erythrocytes having increased in volume and having been destroyed.
Time Course of Changes in Blood Components
The changes in blood components over time are shown in Tables  1 and 2 and Fig. 1 . As the anemia proceeded, the RBC, Hb, Ht, MCV, MCH, MCHC, and Fe values decreased in the untreated group, and there were marked increases in the PLT, reticulocyte, TIBC, and UIBC values. WBC remained unchanged. The RBC, Hb, Ht, and Fe values in the Tokishakuyaku-san group were more significantly increased than in the untreated group. The reticulocyte count was lower than in the untreated group but tended to increase from 15-weeks. TIBC and UIBC values were increased as in the untreated group. MCV began to increase in the Toki-shakuyaku-san group at 19-weeks (after 8 weeks of administration), but examination of erythrocyte morphology revealed less erythrocyte destruction than in the untreated group. The RBC, Hb, Ht, and Fe values showed a trend toward significant improvement in the iron-preparation and the Toki-shakuyaku- sanϩiron-preparation groups, compared to the untreated group. This improvement was more significant than in the Toki-shakuyaku-san group. The reticulocyte count remained unchanged, whereas it remarkably increased in the untreated group.
Changes in Serum Transferrin and Ferritin Values
The changes in transferrin values are shown (Fig. 1) in the form of differences between the values of 10 and 27-weekold-rats (before administration and after 16 weeks of administration). Similar measurements were made in healthy control rats of the same age, and the transferrin values in the untreated group were found to have risen to about 1100 times the normal value. In contrast to the increase in transferrin in the untreated group, it had declined 48.9% in the Tokishakuyaku-san group, 25.1% in the iron-preparation group, and 73.0% in the Toki-shakuyaku-sanϩiron-preparation group. On the other hand, the ferritin values in the untreated group had risen to 2.2 times their level in the healthy control rats. The serum ferritin increased 83.9% in the Toki-shakuyakusan group and 25.9% in the Toki-shakuyaku-sanϩiron-preparation group, but it decreased 15.6% in the iron-preparation group.
Observations of External Appearance The general condition of the 27-week-old drug-administered rats was observed (Table 3) , and the same observations were made of healthy control rats of the same age. The color of the ears, eyes, mouth, tongue, paws, and tail of the healthy control rats was red, and their paw temperature was warm. The color of the untreated group was pale, and the animals' paws were cold. By contrast, color of the Toki-shakuyaku-san group, the iron-preparation group, and the Toki-shakuyaku-sanϩiron-preparation group was reddish-tinged compared to the untreated group, and paw temperature was slightly warmer. In the tail of the iron preparation group, there was a great deal of pigmentation (Fig. 2) ; This was found in 5 of the 5 animals (incidence of pigmentation: 100%). Such pigmentation was not observed in any tails of the Toki-shakuyaku-sanϩ iron-preparation group. Body temperature was 37.1Ϯ0.4°C in the Toki-shakuyaku-san group and 37.1Ϯ0.5°C in the iron-preparation group, and was slightly higher, 37.5Ϯ0.3°C in the Toki-shakuyaku-sanϩiron-preparation group.
Effect on Organ Weight Body weight slowly increased in all of the groups, and there were no differences between them (data not shown). Necropsy was performed in the 27-week-old drug-administered rats, and the organs (brain, thyroid gland, thymus gland, heart, lungs, liver, spleen, stomach, cecum, adrenals, kidneys, testes) were weighed (Table 4) . Healthy control rats of the same age were also necropsied. In the anemic untreated group there was a significant tendency to increase in weight of the heart and spleen and decrease in weight of the stomach. Weights of these three organs tended to be closer to normal in the Toki-shakuyaku-san group than in the untreated group. The weights of the heart and spleen in 874 Vol. 27, No. 6 the iron-preparation group were similar to their weights in the healthy control rats, but there was a clear increase in weight of the stomach. The weights of the heart and spleen tended to be closer to normal and the weight of stomach tended to increase more in the Toki-shakuyaku-sanϩiron-preparation group than in the untreated group. There were no differences from the healthy control rats in the weight of the brain, thyroid gland, thymus gland, lungs, liver, cecum, adrenals, kidneys, or testes in any of the groups.
Organ Examinations At necropsy, the small intestine (duodenum, jejunum, ileum) and large intestine (colon, rectum) were examined in detail with a stereomicroscope in comparison with the organs of the healthy control rats (27 weeks old). The intragastric findings are shown in Fig. 3 . The color of the stomach of the healthy rats was red and circulation was good, whereas in the untreated group the stomach was white, and the wall was thin. In the Toki-shakuyaku-san group, the iron-preparation group, and the Toki-shakuyakusanϩiron-preparation group the stomach wall was redtinged, compared to the untreated group, and the stomach wall in the iron-preparation group was thicker than in the other groups. In addition, petechiae were found in the stomach of 4 of the 5 animals in the iron-preparation group (incidence of petechiae: 80%; mean number of petechiae: 6.75Ϯ 9.0). Petechiae were also observed in 1 of the 6 animals in the untreated group (incidence: 16.7%; mean number: 4), but none were observed in the other preparation groups. The small intestine and large intestine were also examined, and the intestinal wall was thinner and the intestine was narrower in all 4 groups than in the healthy control rats. Petechiae similar to those in the stomach were also observed in parts of the duodenum, jejunum, and colon in the iron-preparation group. The observed symptom is expressed in 5 stages (ϩϩϩ, ϩϩ, ϩ, Ϯ, Ϫ). A healthy control rat which was not administered any drug and bleeding is described as Healthy. On other 4 groups, An untreated group (Untreated), Toki-shakuyaku-san group (T), Iron preparation group (Fe), Toki-shakuyaku-san ϩIron preparation group (TϩFe), it is displayed by the abbreviation in the Table. The rat of all groups were observed in 27 weeks of age. Tail of: A; Healthy, B; Untreated group, C; Toki-shakuyaku-san group, D; Iron preparation group, E; Toki-shakuyaku-sanϩIron preparation group. Groups were observed at 27 weeks of age and healthy control rats not administered any drug and bleeding are described as Healthy.
Fig. 3. Typical Stomach of Each Rat Group Seen by Stereomicroscope
Stomach of: A; Healthy, B; Untreated group, C; Toki-shakuyaku-san group, D; Iron preparation group, E; Toki-shakuyaku-sanϩIron preparation group. Rats were observed at 27 weeks of age and healthy control rats not administered any drug and bleeding are described as Healthy.
A.
B.
C. D. E. RBC of: A; Healthy, B; Untreated group, C; Tokishakuyaku-san group, D; Iron preparation group, E; Tokishakuyaku-sanϩIron preparation group. Rats were observed at 27 weeks of age and healthy control rats not administered any drug and bleeding are described as Healthy.
C. D. E.
Observations of Erythrocyte Morphology Heparinized blood was collected from 27-week-old drug-administered rats before necropsy, and erythrocyte morphology was examined with a light microscope (Fig. 4) . Observations were also made in healthy control rats of the same age. Changes in erythrocyte morphology were observed in the untreated group, and variation in size was also recorded. There were fewer changes in the Toki-shakuyaku-san group, iron-preparation group, and the Toki-shakuyaku-sanϩiron-preparation group, and the contours of the RBC were particularly morphologically distinct in the Toki-shakuyaku-san group.
Determinations of Fecal Number, Wet Weight, and Water Content The number, wet weight, and water content of feces excreted within 24 h were measured (Fig. 5) , and fecal measurements were also made in healthy control rats of the same age. No diarrheic feces were observed in any of the groups. In the healthy control rats the fecal count was 35.0Ϯ12.7, and wet weight was 4.8Ϯ0.2 g. In the anemic state in the untreated group the fecal count and wet weight had decreased considerably, 46.7% and 56.3%, respectively, compared to the values in the healthy control rats. In contrast to the decreases in fecal count and wet weight in the untreated group, increases were 39.3% and 40.6%, respectively, in the Toki-shakuyaku-san group, 23.2% and 15.4% in the iron-preparation group, and 25% and 27.5% in the Tokishakuyaku-sanϩiron-preparation group. Fecal water content was 50.5Ϯ8.7% in the healthy control rats, and there were no differences from the healthy control rats in any of the other 4 groups.
Fecal Iron Content Iron was measured by atomic absorption spectrophotometry in desiccated feces excreted within 24 h, and the fecal iron content of healthy control rats of the same age was also measured. Calculation of mean 24-h iron excretion in each group revealed lower iron content in all 4 groups: the untreated group (94Ϯ6 mg/24 h), Toki-shakuyaku-san group (62Ϯ4 mg/24 h), iron-preparation group (89Ϯ1 mg/24 h), or Toki-shakuyaku-sanϩiron-preparation group (123Ϯ10 mg/24 h) in comparison with the healthy control rats (4893Ϯ76 mg/24 h). There were no significant differences among the 4 groups.
DISCUSSION
In order to examine the proper usage of Toki-shakuyakusan to the iron-deficiency anemia, in the present study we prepared anemic rats and divided them into 4 groups, and assessed their anemia-ameliorating effects and effects on the digestive system.
The decreases in RBC, Hb, Ht, MCV, MCH, MCHC, and Fe values and marked increases in the reticulocyte, TIBC, and UIBC values in the untreated group of rats showed that a state of anemia had developed, and the indices of anemia, i.e., the RBC count, Hb, Ht, reticulocyte, and Fe values, showed a significant trend toward improvement in the ironpreparation group and the Toki-shakuyaku-sanϩiron-preparation group; this was believed to be attributable to the iron supplementation.
On the other hand, RBC, Hb, Ht, Fe values and reticulocytes tended to improve anemia in the Toki-shakuyaku-san group. Based on the microscopic observations, the reason the MCV values (Table 1) in the untreated group had increased from 19-week-old rats (the 8th week of administration) onward appeared to have been that erythrocytes had been destroyed with the increase in reticulocytes. Nevertheless, there was little destruction in the Toki-shakuyaku-san group, and the contours of the RBC had become distinct (Fig. 4) . Although the data are not shown, examination of the bone marrow picture at necropsy revealed an increase in basophilic erythroblasts in the untreated group compared to the healthy control rats, while increases in basophilic erythroblasts and polychromatic erythroblasts were seen in the Toki-shakuyakusan group and iron-preparation group, and increases in erythroblasts as a whole, as well as in basophilic erythroblasts and polychromatic erythroblasts, were seen in the Tokishakuyaku-sanϩiron-preparation group. This is speculated to have been due to participation by Toki-shakuyaku-san in the differentiation and maturation of erythroblasts in the bone marrow, although, determining the mechanism will be the subject of a future study.
Examination of the changes in serum transferrin values and ferritin values between 10 and 27 weeks old (before and after 16 weeks of drug administration: Fig. 1) showed that the former values had decreased in the Toki-shakuyaku-san group, while the latter values had markedly increased. The effect of Toki-shakuyaku-san on transferrin and ferritin is un- known, but it seems likely to be involved in iron storage in the body.
Improvement of the symptoms of anemia was shown by Toki-shakuyaku-san in the earlier clinical study, 7) and the external appearance of each group of rats was evaluated here to confirm this trend (Table 3) . A slight change of the whiteness of the ear, eye and limbs to a thin red color and the limps becoming warm from their formerly cool state in the Toki-shakuyaku-san and the iron-preparation groups. Tokishakuyaku-san is thought to have improved the manifestation of anemia as true in human cases because of its ameliorating effect on blood circulation. 10) This speculation will be confirmed by future experiments.
The weight of the heart and spleen in the untreated group was higher and weight of the stomach lower than in the healthy control rats. The weights of the heart and spleen tended to be closer to normal in the Toki-shakuyaku-san group than in the untreated group, and this was also obvious for the Toki-shakuyaku-sanϩoral iron-preparation group. This is thought to be attributable to action of the drug to reduce heart rate based on reports of its toki and takusha contents. 11, 12) Further, Shi-motsu-tou, which contains four medicinal plants (toki, senkyu, shakuyaku, and jiou) similar to Tokishakuyaku-san, is believed to inhibit the cardiac hypertrophy caused by anemia and to have an ameliorating effect on the circulatory and immune systems. 13) Because of the weight of the anemic spleen comparable to a healthy one after the drug treatment, the suppressed degradation of erythrocytes might be related to the effect of the drug on the anemic spleen.
A significantly smaller number of feces and lower wet weight was noted in the untreated group than in the healthy control rats, while there was a significantly larger number of feces and higher wet weight in the Toki-shakuyaku-san group compared to the untreated group. This is believed attributable to the gastrointestinal-motility-promoting activity of the shakuyaku and sojutsu in Toki-shakuyaku-san. 14) Fecal water content did not differ from the value in healthy control rats in any of the groups. The iron content of feces collected over a 24-h period was lower in all groups than in the healthy control rats, but there were no differences between groups.
Finally, in the iron-preparation group, the hemorrhage of stomach and pigmentation of the tail which seem to be an iron side effect were observed, but not in the Toki-shakuyakusan group. Since there has been a report of the effects of iron preparations on the stomach, 15) when oral administration is prolonged, even small doses appear to have an adverse impact on this organ. However, the fact that there were no gastric petechiae in the Toki-shakuyaku-san group or the Tokishakuyaku-sanϩiron-preparation group, as well as the fact that the weight of the stomach tended to be nearly normal, suggested involvement of Toki-shakuyaku-san in alleviating the gastrointestinal manifestations and mitigating the effect of the iron preparation on the stomach. This is also clear from reports of the medicinal plants shakuyaku, sojutsu, and bukuryo in Toki-shakuyaku-san having anti-ulcer activity. 16, 17) Pigmentation is thought to be an adverse reaction to an iron preparation which is generated by hemochromatosis. 18) In the Toki-shakuyaku-san group, there was no pigmentation in the tail, suggesting that the drug is involved in inhibiting pigmentation.
From the results, which were closely studied in the anemic rats, the Toki-shakuyaku-san group showed improvement in the results of laboratory parameters, hematology, and generaly observed symptoms of anemia; both inhibited the cardiac hypertrophy caused by this condition and lowered the quantity of defecation. It is speculated that these changes are related to the effect on the erythrocyte membrane, the suppression of degradation of erythrocytes in the spleen and iron storage in the body.
Our animal experiments showed that, Toki-shakuyaku-san suppressed the gastrointestinal symptoms of the hemorrhage and pigmentation caused by iron preparation. These results and those we reported earlier on the therapeutic effect of Tokishakuyaku-san on iron-deficiency anemia in uterine myoma, 7) have led us to the conclusion that the use of this drug and an iron preparation in combination, would lessen the adverse gastrointestinal reactions, and provide a better ameliorative effect on the various symptoms of anemia. Therefore, the Kampo medicine Toki-shakuyaku-san is viewed as a potentially raluable drug for anemic patients.
